The Impact Of Aging On Antitumor Immunity And Cancer Immunotherapy
As we age, our bodies undergo many changes, and one crucial system affected is our immune system. This natural decline in immune function, often called “immunosenescence,” has a profound impact on how our bodies detect and fight off diseases like cancer.
Research shows that an aging immune system is less effective at recognizing and eliminating cancerous cells. This is partly due to changes in key immune cells, such as T cells, which are vital for directly attacking tumors. For instance, the number of “fresh” or naive T cells decreases, and the existing T cells may become less functional. Additionally, there can be an increase in cells that suppress the immune response, further hindering the body’s ability to combat cancer.
Beyond the immune cells themselves, the environment surrounding a tumor also changes with age, becoming more conducive for tumor growth and less responsive to immune attacks. These age-related alterations can pose significant challenges for cancer treatments, particularly modern immunotherapies that rely on a robust immune response. Older patients might experience reduced effectiveness from these treatments or even face increased side effects.
Understanding these complex interactions between aging, immunity, and cancer is crucial. It highlights the need for developing new treatment strategies and testing methods that specifically consider the unique biological landscape of older individuals. By doing so, we can work towards more effective and safer cancer therapies for everyone, regardless of age.
Source: link to paper